Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

603
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
603
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

71
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
71
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

62
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
62
Prodrugs01:30

Prodrugs

2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TURBO-RL: turbulence mitigation using reinforcement learning for severe optical aberrations.

Journal of the Optical Society of America. A, Optics, image science, and vision·2026
Same author

Alz-QNet: A quantum regression network for studying Alzheimer's gene interactions.

Computers in biology and medicine·2025
Same author

Modeling Brain Aging With Explainable Triamese ViT: Towards Deeper Insights Into Autism Disorder.

IEEE journal of biomedical and health informatics·2025
Same author

Understanding the natural language of DNA using encoder-decoder foundation models with byte-level precision.

Bioinformatics advances·2024
Same author

Understanding the Natural Language of DNA using Encoder-Decoder Foundation Models with Byte-level Precision.

ArXiv·2024
Same author

Improving Molecule Generation and Drug Discovery with a Knowledge-enhanced Generative Model.

ArXiv·2024
Same journal

A Multi-Modal Framework for Phage-Host Interaction Prediction Using Multi-View Contrastive Learning.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Decoding Gene-Disease Associations with Computational Methods: A Survey.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

A Competitive Coevolution-based Cancer Driver Pathway Identification Algorithm for Maximizing Coverage, Mutual Exclusivity, and Subnet Importance.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Prediction of GO Terms Based on Partitioning PPI Networks into Highly Connected Components.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Parameter Efficient Deep Learning Models for Multi-Target Binding Affinity and hERG Cardiotoxicity Prediction.

IEEE transactions on computational biology and bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K

Improving Molecule Generation and Drug Discovery With a Knowledge-Enhanced Generative Model.

Aditya Malusare, Vaneet Aggarwal

    IEEE Transactions on Computational Biology and Bioinformatics
    |October 9, 2024
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces KARL, a knowledge-enhanced generative model framework. KARL integrates biomedical knowledge graphs to generate valid and synthesizable drug candidates, outperforming existing models.

    More Related Videos

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Modeling an Enzyme Active Site using Molecular Visualization Freeware
    14:37

    Modeling an Enzyme Active Site using Molecular Visualization Freeware

    Published on: December 25, 2021

    9.7K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
    08:21

    Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

    Published on: April 13, 2022

    2.6K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Modeling an Enzyme Active Site using Molecular Visualization Freeware
    14:37

    Modeling an Enzyme Active Site using Molecular Visualization Freeware

    Published on: December 25, 2021

    9.7K

    Area of Science:

    • Artificial Intelligence
    • Cheminformatics
    • Bioinformatics

    Background:

    • Generative models excel at molecule generation but lack biomedical knowledge integration.
    • Biomedical knowledge graphs offer vast potential for enhancing drug discovery.
    • A gap exists between current generative models and leveraging complex biomedical data.

    Purpose of the Study:

    • To bridge the gap between generative models and biomedical knowledge graphs.
    • To develop a novel framework, KARL, for knowledge-enhanced generative drug discovery.
    • To improve the generation of valid and synthesizable drug candidates.

    Main Methods:

    • Developed a scalable methodology to extend knowledge graphs while preserving semantic integrity.
    • Integrated knowledge graph embeddings into a diffusion-based generative model (KARL).
    • Utilized contextual information from knowledge graphs to guide molecule generation.

    Main Results:

    • KARL successfully generated novel drug candidates with specific characteristics.
    • The framework ensured the validity and synthesizability of generated molecules.
    • KARL demonstrated superior performance compared to state-of-the-art models in unconditional and targeted generation.

    Conclusions:

    • KARL represents a significant advancement in knowledge-enhanced generative drug discovery.
    • Integrating knowledge graphs with generative models enhances the quality and relevance of drug candidates.
    • This approach unlocks the potential of biomedical knowledge for AI-driven drug development.